Loading insider details...
Latest Form 4 (Nov 17, 2026): Grant/Award of 70,000 LXEO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 17, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 70,000 | n/a |
| Sep 1, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to Issuer | 7,956 | $676.3K |
| Aug 24, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 471 | n/a |
| Mar 4, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 6,713 | $266.3K |
| Feb 25, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 32,000 | n/a |
| Mar 11, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 52,000 | n/a |
| Jul 2, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 1,000 | $2.2K |
| Mar 19, 2024 | Revance Therapeutics, Inc. (RVNC) | Tax Withholding | 3,822 | $20.3K |
| Mar 4, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 17,447 | n/a |
| Feb 2, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 96,667 | n/a |